Tekhnovo

Tekhnovo
Teknova provides critical reagents for biopharmaceutical product development and production.
About
What does Tekhnovo do?
Teknova is a life sciences company that manufactures critical reagents for the development and production of biopharmaceutical products, including drug therapies, novel vaccines, and molecular diagnostics. They offer customizable solutions for various stages of workflow, from research to GMP production, supporting areas like cell and gene therapy, mRNA therapeutics, and genomics.
What is Tekhnovo's revenue?
StartupHub estimates Tekhnovo's annual revenue at $20.1M (range $11.2M to $29.0M, 62% confidence), based on comparable companies in the sector.
Where is Tekhnovo headquartered?
Tekhnovo is headquartered in Hollister, United Kingdom.
When was Tekhnovo founded?
Tekhnovo was founded in 2023.
What industry does Tekhnovo operate in?
Tekhnovo operates in Biotech, MedTech, HealthTech, Genomics, Drug Discovery, Clinical Trials.
How many employees does Tekhnovo have?
Tekhnovo has approximately 182 people on record.
What is Tekhnovo's current status?
Tekhnovo's current operating status is: Inactive.
No comments yet. Be the first to share your take.